IDEAS home Printed from https://ideas.repec.org/a/sae/envira/v30y1998i10p1723-1741.html
   My bibliography  Save this article

The Indianapolis ‘Fortune 500’: Lilly and Regional Renaissance

Author

Listed:
  • S M Walcott

    (Department of Geography, Georgia State University, Atlanta, GA 30303-3083, USA)

Abstract

The reasons for and consequences of the location of a flourishing industrial anomaly ouside the predominant region of concentration is of continuing geographic interest. This paper is an examination of both structural and agency factors for the historical establishment and consistent success of pharmaceutical giant Eli Lilly and Company. Along with its recent medical device spinoff, Lilly is the only ‘Fortune 500’ firm in Indianapolis, and one of few outside the Mid-Atlantic states cluster. Industry-locational exceptionalism is sustained by a cross-sectoral concentration of related manufacturing and service companies to create a health ensemble. A consciously constructed local metropolitan and state sociopolitical niche further nurtures industry-specific and mutually beneficial growth. Theories on agglomeration-sustaining patterns are considered in light of this empirical study.

Suggested Citation

  • S M Walcott, 1998. "The Indianapolis ‘Fortune 500’: Lilly and Regional Renaissance," Environment and Planning A, , vol. 30(10), pages 1723-1741, October.
    • Handle: RePEc:sae:envira:v:30:y:1998:i:10:p:1723-1741
    DOI: 10.1068/a301723
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1068/a301723
    Download Restriction: no
    File URL: https://libkey.io/10.1068/a301723?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Feldman, Maryann & Schreuder, Yda, 1996. "Initial Advantage: The Origins of the Geographic Concentration of the Pharmaceutical Industry in the Mid-Atlantic Region," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 5(3), pages 839-862.
    2. Gambardella,Alfonso, 1995. "Science and Innovation," Cambridge Books, Cambridge University Press, number 9780521451185.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Jeffrey Furman & Margaret K. Kyle & Alain Cockburn & Rebecca M. Henderson, 2005. "Public & Private Spillovers: Location and the Productivity of Pharmaceutical Research," Annals of Economics and Statistics, GENES, issue 79-80, pages 165-188.
    2. Christian Zeller, 2010. "The Pharma-biotech Complex and Interconnected Regional Innovation Arenas," Urban Studies, Urban Studies Journal Limited, vol. 47(13), pages 2867-2894, November.
    3. Garavaglia Christian & Malerba Franco & Orsenigo Luigi & Pezzoni Michele, 2014. "Innovation and Market Structure in Pharmaceuticals: An Econometric Analysis on Simulated Data," Journal of Economics and Statistics (Jahrbuecher fuer Nationaloekonomie und Statistik), De Gruyter, vol. 234(2-3), pages 274-298, April.
    4. Stefano Brusoni & Paola Criscuolo & Aldo Geuna, 2005. "The knowledge bases of the world's largest pharmaceutical groups: what do patent citations to non-patent literature reveal?," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 14(5), pages 395-415.
    5. Lee Branstetter & Kwon Hyeog Ug, 2004. "The Restructuring Of Japanese Research And Development: The Increasing Impact Of Science On Japanese R&D," Discussion papers 04021, Research Institute of Economy, Trade and Industry (RIETI).
    6. Cassiman, Bruno & Veugelers, Reinhilde & Arts, Sam, 2018. "Mind the gap: Capturing value from basic research through combining mobile inventors and partnerships," Research Policy, Elsevier, vol. 47(9), pages 1811-1824.
    7. Laura Magazzini & Fabio Pammolli & Massimo Riccaboni & Maria Alessandra Rossi, 2009. "Patent disclosure and R&D competition in pharmaceuticals," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 18(5), pages 467-486.
    8. Lanjouw, J.O., 1997. "The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"?," Papers 775, Yale - Economic Growth Center.
    9. Scherer, F. M., 2007. "Pharmaceutical Innovation," Working Paper Series rwp07-004, Harvard University, John F. Kennedy School of Government.
    10. Farasat A. S. Bokhari & Franco Mariuzzo & Anna Rita Bennato, 2021. "Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions," Small Business Economics, Springer, vol. 57(1), pages 603-634, June.
    11. Iain Cockburn & Rebecca Henderson & Scott Stern, 1999. "The Diffusion of Science-Driven Drug Discovery: Organizational Change in Pharmaceutical Research," NBER Working Papers 7359, National Bureau of Economic Research, Inc.
    12. G. Steven McMillan & Alfredo Mauri & Robert D. Halmilton, 2003. "The Impact of Publishing and Patenting Activities on New Product Development and Firm Performance: The Case of the US Pharmaceutical Industry," International Journal of Innovation Management (ijim), World Scientific Publishing Co. Pte. Ltd., vol. 7(02), pages 213-221.
    13. Malo, Stéphane, 2009. "The contribution of (not so) public research to commercial innovations in the field of combinatorial chemistry," Research Policy, Elsevier, vol. 38(6), pages 957-970, July.
    14. Stephan, Michael, 2013. "Theorien der Industrieevolution," Discussion Papers on Strategy and Innovation 13-03, Philipps-University Marburg, Department of Technology and Innovation Management (TIM).
    15. Kravtsova, Victoria & Radosevic, Slavo, 2012. "Are systems of innovation in Eastern Europe efficient?," Economic Systems, Elsevier, vol. 36(1), pages 109-126.
    16. Mariana Mazzucato & Massimiliano Tancioni, 2013. "R&D, Patents and Stock Return Volatility," Economic Complexity and Evolution, in: Andreas Pyka & Esben Sloth Andersen (ed.), Long Term Economic Development, edition 127, pages 341-362, Springer.
    17. Heide Fier & Andreas Pyka, 2014. "Against the one-way-street: analyzing knowledge transfer from industry to science," The Journal of Technology Transfer, Springer, vol. 39(2), pages 219-246, April.
    18. Iain M. Cockburn & Scott Stern & Jack Zausner, 2011. "Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Energy R&D," NBER Chapters, in: Accelerating Energy Innovation: Insights from Multiple Sectors, pages 113-157, National Bureau of Economic Research, Inc.
    19. Lindholm-Dahlstrand, Asa & Andersson, Martin & Carlsson, Bo, 2016. "Entrepreneurial Experimentation: A key function in Entrepreneurial Systems of Innovation," Papers in Innovation Studies 2016/20, Lund University, CIRCLE - Centre for Innovation Research.
    20. Subramanian, Annapoornima M. & Lim, Kwanghui & Soh, Pek-Hooi, 2013. "When birds of a feather don’t flock together: Different scientists and the roles they play in biotech R&D alliances," Research Policy, Elsevier, vol. 42(3), pages 595-612.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:envira:v:30:y:1998:i:10:p:1723-1741. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.